Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,406 | 7,679 | 10,413 | 12,556 | 14,655 |
| Other current assets | 12 | 0 | 0 | 0 | 0 |
| TOTAL | $5,585 | $7,930 | $10,748 | $13,144 | $14,827 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 12 | 12 | 12 | 12 |
| TOTAL | $N/A | $12 | $12 | $12 | $12 |
| Total Assets | $5,585 | $7,942 | $10,759 | $13,156 | $14,838 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 546 | 1,049 | 1,721 | 1,122 | 549 |
| Accrued Expenses | 650 | 1,026 | 928 | 758 | 587 |
| TOTAL | $1,196 | $2,075 | $2,649 | $1,879 | $1,136 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 3,701 | 6,051 | 4,507 | 5,769 |
| TOTAL | $N/A | $3,701 | $6,051 | $4,507 | $5,769 |
| Total Liabilities | $1,196 | $5,776 | $8,700 | $6,386 | $6,905 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116 | 108 | 107 | 107 | 107 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -73,021 | -71,039 | -70,730 | -65,487 | -63,861 |
| TOTAL | $4,389 | $2,166 | $2,060 | $6,770 | $7,934 |
| Total Liabilities And Equity | $5,585 | $7,942 | $10,759 | $13,156 | $14,838 |